Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Xue Yi
Activated Hepatic Stellate Cells (HSCs) Exert Immunosuppressive Effects in Hepatocellular Carcinoma by Producing Complement C3
OncoTargets and Therapy
Oncology
Pharmacology
Related publications
Activated Hepatic Stellate Cells Promote Hepatocellular Carcinoma Cell Migration and Invasion via the Activation of FAK-MMP9 Signaling
Oncology Reports
Medicine
Cancer Research
Oncology
Soluble FGL2, a Novel Effector Molecule of Activated Hepatic Stellate Cells, Regulates T-Cell Function in Cirrhotic Patients With Hepatocellular Carcinoma
Hepatology International
Hepatology
Hepatic Stellate Cells Transmigration and Remodeling Are Related to CCN3 in Oxaliplatin-Resistant Hepatocellular Carcinoma
Oncotarget
Oncology
Activated Hepatic Stellate Cells: Negative Regulators of Hepatocyte Proliferation in Liver Diseases
Hepatology
Medicine
Hepatology
Systemic PEGylated TRAIL Treatment Ameliorates Liver Cirrhosis in Rats by Eliminating Activated Hepatic Stellate Cells
Hepatology
Medicine
Hepatology
B7-H4 Mediates Inhibition of T Cell Responses by Activated Murine Hepatic Stellate Cells
Hepatology
Medicine
Hepatology
Hypoxia-Induced Secretion of Platelet-Derived Growth Factor-Bb by Hepatocellular Carcinoma Cells Increases Activated Hepatic Stellate Cell Proliferation, Migration and Expression of Vascular Endothelial Growth Factor-A
Molecular Medicine Reports
Oncology
Genetics
Molecular Biology
Biochemistry
Cancer Research
Molecular Medicine
Angiotensinogen-Producing Hepatocellular Carcinoma.
Hypertension
Internal Medicine
High Immunosuppressive Burden in Advanced Hepatocellular Carcinoma Patients
OncoImmunology
Oncology
Allergy
Immunology
